Serum anti-glycan-antibodies in relatives of patients with inflammatory bowel disease.
Serum anti-glycan antibodies are a promising tool for differential diagnosis, disease stratification and prediction of Crohn's disease (CD). To investigate possible heritability of the markers we assessed the presence of serum anti-glycan antibodies in affected and unaffected relatives of patie...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2018-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC5875751?pdf=render |
| _version_ | 1811211925728526336 |
|---|---|
| author | Florian Kamm Ulrike Strauch Frauke Degenhardt Rocio Lopez Claudia Kunst Gerhard Rogler Andre Franke Frank Klebl Florian Rieders |
| author_facet | Florian Kamm Ulrike Strauch Frauke Degenhardt Rocio Lopez Claudia Kunst Gerhard Rogler Andre Franke Frank Klebl Florian Rieders |
| author_sort | Florian Kamm |
| collection | DOAJ |
| description | Serum anti-glycan antibodies are a promising tool for differential diagnosis, disease stratification and prediction of Crohn's disease (CD). To investigate possible heritability of the markers we assessed the presence of serum anti-glycan antibodies in affected and unaffected relatives of patients with CD.Serum samples of 169 IBD patients of the German inflammatory bowel disease (IBD) network (140 CD & 29 Ulcerative colitis (UC)), 349 relatives of CD patients, 63 relatives of UC patients and 46 healthy controls were tested for the presence of anti-glycan antibodies by ELISA in a blinded fashion. Clinical data of the IBD patients and controls were available.A higher proportion of non-affected CD relatives was positive for anti-glycan antibodies compared to healthy subjects. No inheritance of a specific pattern of anti-glycan antibodies could be detected. No difference in marker expression depending on the degree of relationship in the non-affected relatives was noted and the presence of family history did not lead to a difference in marker levels in the affected CD subjects.Non-affected CD relatives had a higher frequency of anti-glycan antibodies compared to healthy subjects. This difference was mild and was found to be true for the overall reactivity to glycan antigens, but not for specific patterns. This may indicate an inherited mechanism resulting in a non-specific increased reactivity to microbial antigens in IBD. |
| first_indexed | 2024-04-12T05:21:39Z |
| format | Article |
| id | doaj.art-ba9720f8683a4039acb163fc7d93ace9 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-04-12T05:21:39Z |
| publishDate | 2018-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-ba9720f8683a4039acb163fc7d93ace92022-12-22T03:46:28ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-01133e019422210.1371/journal.pone.0194222Serum anti-glycan-antibodies in relatives of patients with inflammatory bowel disease.Florian KammUlrike StrauchFrauke DegenhardtRocio LopezClaudia KunstGerhard RoglerAndre FrankeFrank KleblFlorian RiedersSerum anti-glycan antibodies are a promising tool for differential diagnosis, disease stratification and prediction of Crohn's disease (CD). To investigate possible heritability of the markers we assessed the presence of serum anti-glycan antibodies in affected and unaffected relatives of patients with CD.Serum samples of 169 IBD patients of the German inflammatory bowel disease (IBD) network (140 CD & 29 Ulcerative colitis (UC)), 349 relatives of CD patients, 63 relatives of UC patients and 46 healthy controls were tested for the presence of anti-glycan antibodies by ELISA in a blinded fashion. Clinical data of the IBD patients and controls were available.A higher proportion of non-affected CD relatives was positive for anti-glycan antibodies compared to healthy subjects. No inheritance of a specific pattern of anti-glycan antibodies could be detected. No difference in marker expression depending on the degree of relationship in the non-affected relatives was noted and the presence of family history did not lead to a difference in marker levels in the affected CD subjects.Non-affected CD relatives had a higher frequency of anti-glycan antibodies compared to healthy subjects. This difference was mild and was found to be true for the overall reactivity to glycan antigens, but not for specific patterns. This may indicate an inherited mechanism resulting in a non-specific increased reactivity to microbial antigens in IBD.http://europepmc.org/articles/PMC5875751?pdf=render |
| spellingShingle | Florian Kamm Ulrike Strauch Frauke Degenhardt Rocio Lopez Claudia Kunst Gerhard Rogler Andre Franke Frank Klebl Florian Rieders Serum anti-glycan-antibodies in relatives of patients with inflammatory bowel disease. PLoS ONE |
| title | Serum anti-glycan-antibodies in relatives of patients with inflammatory bowel disease. |
| title_full | Serum anti-glycan-antibodies in relatives of patients with inflammatory bowel disease. |
| title_fullStr | Serum anti-glycan-antibodies in relatives of patients with inflammatory bowel disease. |
| title_full_unstemmed | Serum anti-glycan-antibodies in relatives of patients with inflammatory bowel disease. |
| title_short | Serum anti-glycan-antibodies in relatives of patients with inflammatory bowel disease. |
| title_sort | serum anti glycan antibodies in relatives of patients with inflammatory bowel disease |
| url | http://europepmc.org/articles/PMC5875751?pdf=render |
| work_keys_str_mv | AT floriankamm serumantiglycanantibodiesinrelativesofpatientswithinflammatoryboweldisease AT ulrikestrauch serumantiglycanantibodiesinrelativesofpatientswithinflammatoryboweldisease AT fraukedegenhardt serumantiglycanantibodiesinrelativesofpatientswithinflammatoryboweldisease AT rociolopez serumantiglycanantibodiesinrelativesofpatientswithinflammatoryboweldisease AT claudiakunst serumantiglycanantibodiesinrelativesofpatientswithinflammatoryboweldisease AT gerhardrogler serumantiglycanantibodiesinrelativesofpatientswithinflammatoryboweldisease AT andrefranke serumantiglycanantibodiesinrelativesofpatientswithinflammatoryboweldisease AT frankklebl serumantiglycanantibodiesinrelativesofpatientswithinflammatoryboweldisease AT florianrieders serumantiglycanantibodiesinrelativesofpatientswithinflammatoryboweldisease |